List of Chapters/Sections(Table Of Content)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Adalimumab Injection
1.2 Key Market Segments
1.2.1 Adalimumab Injection Segment by Type
1.2.2 Adalimumab Injection Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Adalimumab Injection Market Overview
2.1 Global Market Overview
2.1.1 Global Adalimumab Injection Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Adalimumab Injection Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Adalimumab Injection Market Competitive Landscape
3.1 Global Adalimumab Injection Sales by Manufacturers (2019-2024)
3.2 Global Adalimumab Injection Revenue Market Share by Manufacturers (2019-2024)
3.3 Adalimumab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Adalimumab Injection Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Adalimumab Injection Sales Sites, Area Served, Product Type
3.6 Adalimumab Injection Market Competitive Situation and Trends
3.6.1 Adalimumab Injection Market Concentration Rate
3.6.2 Global 5 and 10 Largest Adalimumab Injection Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Adalimumab Injection Industry Chain Analysis
4.1 Adalimumab Injection Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Adalimumab Injection Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Adalimumab Injection Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adalimumab Injection Sales Market Share by Type (2019-2024)
6.3 Global Adalimumab Injection Market Size Market Share by Type (2019-2024)
6.4 Global Adalimumab Injection Price by Type (2019-2024)
7 Adalimumab Injection Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adalimumab Injection Market Sales by Application (2019-2024)
7.3 Global Adalimumab Injection Market Size (M USD) by Application (2019-2024)
7.4 Global Adalimumab Injection Sales Growth Rate by Application (2019-2024)
8 Adalimumab Injection Market Segmentation by Region
8.1 Global Adalimumab Injection Sales by Region
8.1.1 Global Adalimumab Injection Sales by Region
8.1.2 Global Adalimumab Injection Sales Market Share by Region
8.2 North America
8.2.1 North America Adalimumab Injection Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Adalimumab Injection Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Adalimumab Injection Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Adalimumab Injection Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Adalimumab Injection Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AbbVie
9.1.1 AbbVie Adalimumab Injection Basic Information
9.1.2 AbbVie Adalimumab Injection Product Overview
9.1.3 AbbVie Adalimumab Injection Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Adalimumab Injection SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 Amgen
9.2.1 Amgen Adalimumab Injection Basic Information
9.2.2 Amgen Adalimumab Injection Product Overview
9.2.3 Amgen Adalimumab Injection Product Market Performance
9.2.4 Amgen Business Overview
9.2.5 Amgen Adalimumab Injection SWOT Analysis
9.2.6 Amgen Recent Developments
9.3 Sandoz
9.3.1 Sandoz Adalimumab Injection Basic Information
9.3.2 Sandoz Adalimumab Injection Product Overview
9.3.3 Sandoz Adalimumab Injection Product Market Performance
9.3.4 Sandoz Adalimumab Injection SWOT Analysis
9.3.5 Sandoz Business Overview
9.3.6 Sandoz Recent Developments
9.4 Fresenius Kabi
9.4.1 Fresenius Kabi Adalimumab Injection Basic Information
9.4.2 Fresenius Kabi Adalimumab Injection Product Overview
9.4.3 Fresenius Kabi Adalimumab Injection Product Market Performance
9.4.4 Fresenius Kabi Business Overview
9.4.5 Fresenius Kabi Recent Developments
9.5 Biogen
9.5.1 Biogen Adalimumab Injection Basic Information
9.5.2 Biogen Adalimumab Injection Product Overview
9.5.3 Biogen Adalimumab Injection Product Market Performance
9.5.4 Biogen Business Overview
9.5.5 Biogen Recent Developments
9.6 Celltrion
9.6.1 Celltrion Adalimumab Injection Basic Information
9.6.2 Celltrion Adalimumab Injection Product Overview
9.6.3 Celltrion Adalimumab Injection Product Market Performance
9.6.4 Celltrion Business Overview
9.6.5 Celltrion Recent Developments
9.7 Cadila Pharmaceuticals
9.7.1 Cadila Pharmaceuticals Adalimumab Injection Basic Information
9.7.2 Cadila Pharmaceuticals Adalimumab Injection Product Overview
9.7.3 Cadila Pharmaceuticals Adalimumab Injection Product Market Performance
9.7.4 Cadila Pharmaceuticals Business Overview
9.7.5 Cadila Pharmaceuticals Recent Developments
9.8 Bio-Thera Solutions, Ltd.
9.8.1 Bio-Thera Solutions, Ltd. Adalimumab Injection Basic Information
9.8.2 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Overview
9.8.3 Bio-Thera Solutions, Ltd. Adalimumab Injection Product Market Performance
9.8.4 Bio-Thera Solutions, Ltd. Business Overview
9.8.5 Bio-Thera Solutions, Ltd. Recent Developments
9.9 Hisun Biopharmaceutical
9.9.1 Hisun Biopharmaceutical Adalimumab Injection Basic Information
9.9.2 Hisun Biopharmaceutical Adalimumab Injection Product Overview
9.9.3 Hisun Biopharmaceutical Adalimumab Injection Product Market Performance
9.9.4 Hisun Biopharmaceutical Business Overview
9.9.5 Hisun Biopharmaceutical Recent Developments
9.10 Innovent Biologics
9.10.1 Innovent Biologics Adalimumab Injection Basic Information
9.10.2 Innovent Biologics Adalimumab Injection Product Overview
9.10.3 Innovent Biologics Adalimumab Injection Product Market Performance
9.10.4 Innovent Biologics Business Overview
9.10.5 Innovent Biologics Recent Developments
9.11 Mylan
9.11.1 Mylan Adalimumab Injection Basic Information
9.11.2 Mylan Adalimumab Injection Product Overview
9.11.3 Mylan Adalimumab Injection Product Market Performance
9.11.4 Mylan Business Overview
9.11.5 Mylan Recent Developments
9.12 Zydus Group
9.12.1 Zydus Group Adalimumab Injection Basic Information
9.12.2 Zydus Group Adalimumab Injection Product Overview
9.12.3 Zydus Group Adalimumab Injection Product Market Performance
9.12.4 Zydus Group Business Overview
9.12.5 Zydus Group Recent Developments
9.13 Boehringer Ingelheim
9.13.1 Boehringer Ingelheim Adalimumab Injection Basic Information
9.13.2 Boehringer Ingelheim Adalimumab Injection Product Overview
9.13.3 Boehringer Ingelheim Adalimumab Injection Product Market Performance
9.13.4 Boehringer Ingelheim Business Overview
9.13.5 Boehringer Ingelheim Recent Developments
9.14 Jiangsu Chia Tai-Tianqing Pharmaceutical
9.14.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Basic Information
9.14.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Overview
9.14.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Product Market Performance
9.14.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Business Overview
9.14.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments
9.15 Shanghai Henlius Biotech
9.15.1 Shanghai Henlius Biotech Adalimumab Injection Basic Information
9.15.2 Shanghai Henlius Biotech Adalimumab Injection Product Overview
9.15.3 Shanghai Henlius Biotech Adalimumab Injection Product Market Performance
9.15.4 Shanghai Henlius Biotech Business Overview
9.15.5 Shanghai Henlius Biotech Recent Developments
10 Adalimumab Injection Market Forecast by Region
10.1 Global Adalimumab Injection Market Size Forecast
10.2 Global Adalimumab Injection Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Adalimumab Injection Market Size Forecast by Country
10.2.3 Asia Pacific Adalimumab Injection Market Size Forecast by Region
10.2.4 South America Adalimumab Injection Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Adalimumab Injection by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Adalimumab Injection Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Adalimumab Injection by Type (2025-2030)
11.1.2 Global Adalimumab Injection Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Adalimumab Injection by Type (2025-2030)
11.2 Global Adalimumab Injection Market Forecast by Application (2025-2030)
11.2.1 Global Adalimumab Injection Sales (Kilotons) Forecast by Application
11.2.2 Global Adalimumab Injection Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
